Repeatability of indices of insulin sensitivity and secretion from standard liquid meal tests in subjects with type 2 diabetes mellitus or normal or impaired fasting glucose

Diabetes Technology and Therapeutics

Volumn 12, Issue 11, 2010, Pages 895-900

  Maki, Kevin C ^a   Rains, Tia M ^a   Dicklin, Mary R ^a   Bell, Marjorie ^b  

^a Provident Clinical Research   (United States)

^b ClinDataServices   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISPOSITION INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MATSUDA INDEX; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; TEST MEAL; TEST RETEST RELIABILITY;

ADOLESCENT; ADULT; AGED; AGING; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; EATING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 78649388428     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0083     Document Type: Article

References (33)

1. National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics 2007 Fact Sheet. Bethesda MD: National Institutes of Health, U.S. Department of Health and Human Services 2008.
2. DeFronzo RA: Lilly Lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
3. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794.
4. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334:299-308.
5. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr: Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001;131:354S-360S.
6. Porte D Jr, Kahn SE: Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 2001;50(Suppl 1): S160-S163.
7. Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contribution of beta-cell dysfunction and insulin resistance to the patho-genesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139.
8. Cobelli C, Toffolo GM, Dalla Man C, Camiono M, Denti P, Caumo A, Butler P, Rizza R: Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007;293:E1-E15.
9. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
10. Monzillo LU, Hamdy O: Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003;61: 397-412.
11. Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:E15-E26.
12. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B: Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 2008;16:1901-1907.
13. DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi ME, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group: Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia 2010; 53:435-445.
14. Aloulou I, Brun JF, Mercier J: Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with minimal model analysis of an intravenous glucose tolerance test. Metabolism 2006;55: 676-690.
15. Caumo A, Bergman RN, Cobelli C: Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab 2000;85:4396-4402.
16. Steil GM, Hwu CM, Janowski R, Hariri F, Jinagouda S, Darwin C, Tadros S, Rebrin K, Saad MF: Evaluation of insulin-sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. Diabetes 2004;53:1201-1207.
17. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672.
18. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3-19.
19. Maki KC, McKenney JM, Farmer MV, Reeves MS, Dicklin MR: Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose. Nutr J 2009;8:22.
20. Maki KC, Curry LL, Reeves MS, Toth PD, McKenney JM, Farmer MV, Schwartz SL, Lubin BC, Boileau AC, Dicklin MR, Carakostas MC, Tarka SM: Chronic consumption of re-baudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 2008;46(Suppl 7): S47-S53.
21. Wheeler A, Boileau AC, Winkler PC, Compton JC, Prakash I, Jiang X, Mandarino DA: Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Food Chem Toxicol 2008;46(Suppl 7):S54-S60.
22. American Diabetes Association: Standards of medical care in diabetes\2007. Diabetes Care 2007;30(Suppl I):S4-S41.
23. Gruber CA, Koets MD: Quantitation of hemoglobin A1a\+b and hemoglobin A1c by automated "high-performance" liquid chromatography. Clin Chem 1979;25:1970-1971.
24. Cefalu WT, Wang AQ, Bell-Farrow A, Kiger FD, Izlar C: Glycohemoglobin measured by automated HPLC correlated with both short-term and long-term antecedent glycemia. Clin Chem 1994;40:1317-1321.
25. Kadish AH, Hall DA: A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem 1965;11:869-875.
26. Allauzen S, Joly S, Granier C, Molina F, Bouix O, Pau B, Bouanani M: Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionary conserved residues. Mol Immunol 1995;32:27-36.
27. Portney LG, Watkins MP: Foundations of Clinical Research: Applications to Practice. Norwalk, CT: Appleton and Lange, 1993:352.
28. th ed. New York: McGraw-Hill, 1997.
29. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN: Prior short-term consumption of resistant starch enhances post-prandial insulin sensitivity in healthy subjects. Diabetologia 2003;46:659-665.
30. Cozma LS, Luzio SD, Dunseath GJ, Underwood PM, Owens DR: Beta-cell response during a meal test. Diabetes Care 2005;28:1001-1007.
31. Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza RA, Toffolo G, Cobelli C: Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of b-cell responsivity and insulin sensitivity in non-diabetic individuals. Diabetes 2005;54:3265-3273.
32. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ: Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008;57:678-687.
33. Hücking K, Watanabe RM, Stefanolvski D, Bergman RN: OGTT-derived measures of insulin sensitivity confounded by factors other than insulin sensitivity itself. Obesity (Silver Spring) 2008;16:1938-1945.